article = {SCR-2020-2-112}
title = {Oncoplastic Management of a Giant Buschke Lowenstein Genital Tumor in a Nonimmunocompromised Patient}
journal = {Surgical Case Reports}
year = {2020}
issn = {2613-5965}
doi = {http://dx.doi.org/10.31487/j.SCR.2020.02.12}
url = {https://www.sciencerepository.org/oncoplastic-management-of-a-giant-buschke-lowenstein-genital-tumor-in_SCR-2020-2-112 
author = {M.  Rimbault,L.  Paquier,M.  Tooulou,N.  Abboud,Philippe Simon,}
keywords = {Bushke lowenstein, oncoplastic surger, vulvar carcinoma}
abstract ={Buschke-Löwenstein tumor (BLT) is a rare but impressive and aggressive entity and is mostly associated
with Human Papilloma Virus (HPV) 6 or 11 infection in immunocompromised patients. It stands out
because of the importance of the recurrences and the risk of progression to a malignant tumor. The first-line
treatment remains local radical surgery. Other treatments are controversial, including radiotherapy,
chemotherapy, and immunotherapy. We report a new case regarding the management of a giant BLT in a
non-immunocompromised woman, treated in a three-staged approach, starting with a radical excisional
surgery, followed by a delayed reconstruction and then radiotherapy.}